ANGPT2 & VEGFA, Human (Faricimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-ANGPT2 & VEGFA, Human (Faricimab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityANGPT2 & VEGFA, Human (Faricimab biosimilar)
CloneFaricimab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human ANGPT2 & VEGFA Recombinant Antibody (Faricimab). Faricimab (INN) is a bispecific monoclonal antibody that is being investigated for diabetic macular edema. This drug is being developed by Hoffmann-La Roche. As of 2018, faricimab is undergoing Phase III trials.
Immunogenn/a
Other NamesAnti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Faricimab, Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Faricimab), RG7716, RO6867461, Antibody Drug Analogues, Monoclonal Antibody, YR1492, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1607793-29-2
Catalog #YR1492
Priceplease inquire
Order / More InfoANGPT2 & VEGFA, Human (Faricimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.